BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mori A, Arimoto A, Hamaguchi Y, Kajiwara M, Nakajima A, Kanaya S. Risk Factors and Outcome of Portal Vein Thrombosis After Laparoscopic and Open Hepatectomy for Primary Liver Cancer: A Single-Center Experience. World J Surg 2020;44:3093-9. [PMID: 32394012 DOI: 10.1007/s00268-020-05565-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Zhu F, Wang B, Zhou Y, Xiong H, Fan T, Ke W. Clinical Effect of Iodine-125 Seed Implantation in Patients with Primary Liver Cancer and Its Effect on Th1/Th2 Cells in Peripheral Blood. J Oncol 2021;2021:6199732. [PMID: 34367285 DOI: 10.1155/2021/6199732] [Reference Citation Analysis]
2 Onda S, Furukawa K, Shirai Y, Hamura R, Horiuchi T, Yasuda J, Shiozaki H, Gocho T, Shiba H, Ikegami T. New classification-oriented treatment strategy for portal vein thrombosis after hepatectomy. Ann Gastroenterol Surg 2020;4:701-9. [PMID: 33319161 DOI: 10.1002/ags3.12383] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Li H, Sun PM, Sun HW, Cui Y. Progress in clinical diagnosis and treatment of cavernous transformation of the portal vein. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 662-669 [DOI: 10.11569/wcjd.v29.i12.662] [Reference Citation Analysis]
4 Mori A, Arimoto A, Hamaguchi Y, Kajiwara M, Nakajima A, Kanaya S. Author's Reply: Risk Factors and Outcome of Portal Vein Thrombosis After Laparoscopic and Open Hepatectomy for Primary Liver Cancer: A Single-Center Experience. World J Surg 2020;44:3973-4. [PMID: 32734452 DOI: 10.1007/s00268-020-05716-7] [Reference Citation Analysis]
5 Onda S, Furukawa K, Gocho T, Shirai Y, Yasuda J, Shiozaki H, Hamura R, Ikegami T. Letter to the Editor: Risk Factors and Outcome of Portal Vein Thrombosis After Laparoscopic and Open Hepatectomy for Primary Liver Cancer: A Single-Center Experience. World J Surg 2020;44:3971-2. [PMID: 32661694 DOI: 10.1007/s00268-020-05690-0] [Reference Citation Analysis]
6 Jia Y, Xing Y, Yang M. Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT. J Oncol 2021;2021:9120265. [PMID: 34434234 DOI: 10.1155/2021/9120265] [Reference Citation Analysis]